Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Gelesis Holdings, Inc. (OTC : GLSHQ) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Gelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation.
Quote
| Last: | $0.0001 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $0.0001 |
| Close: | $0.0001 |
| High: | $0.0001 |
| Low: | $0.0001 |
| Volume: | 4,455 |
| Last Trade Date Time: | 09/22/2025 11:00:12 am |
Stock Data
| Market Cap: | $73 |
|---|---|
| Float: | 58,741,423 |
| Insiders Ownership: | 2.05% |
| Institutions: | 3 |
| Short Percent: | 695139% |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Country: | US |
| City: | Boston |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Gelesis Holdings, Inc. (OTC: GLSHQ).
